Clinical Trial

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the selection of the IOLs and can lead to visual outcomes that are unpredictable. Data from an international registry and single prospective study show that Vivity IOL provided effective distance, intermediate and near vision in eyes with previous LASIK with minimal effects on day vision associated with the surgery. The purpose of this study is to evaluate the clinical outcomes of post-myopic refractive surgery patients implanted with the Clareon Vivity/Vivity Toric lenses
Trial Details
NCT Number NCT06924944
Lead Sponsor Utah Eye Centers
Conditions Correction Vision Surgery, Cataract Surgery
Enrollment 35 participants
Start Date 2025-01-20
Primary Completion 2025-12 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-13